Meridian Bioscience Receives NIH Contract for Production of Experimental Vaccines

Meridian Bioscience announced that it has received a five-year contract having a value of up to $12.2 million by the National Institutes of Allergy and Infectious Diseases of the National Institutes of Health.
RTTNews